Kura Oncology (KURA) Change in Acquisitions & Divestments (2016 - 2026)

Kura Oncology (KURA) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $147.5 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 11.99% year-over-year to $147.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $735.0 million (up 17.47% YoY) and the FY2025 annual result came in at $755.1 million, up 35.34% from the prior year.
• Change in Acquisitions & Divestments fell to $147.5 million in Q1 2026 per KURA's latest filing, from $177.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $235.0 million in Q3 2025 and bottomed at $26.5 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $129.1 million (2022), against an average of $128.8 million.
• The widest annual swing landed in 2022, when Change in Acquisitions & Divestments slumped 35.01%; it then surged 220.91% in 2023.
• Tracing KURA's Change in Acquisitions & Divestments over 5 years: stood at $58.8 million in 2022, then surged by 141.26% to $141.9 million in 2023, then climbed by 2.89% to $146.0 million in 2024, then advanced by 21.58% to $177.5 million in 2025, then fell by 16.9% to $147.5 million in 2026.
• Per Business Quant, the three latest KURA Change in Acquisitions & Divestments figures stand at $147.5 million (Q1 2026), $177.5 million (Q4 2025), and $235.0 million (Q3 2025).

Peer Comparison